Truvestments Capital LLC Aeterna Zentaris Inc. Transaction History

Truvestments Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$0.17 - $0.37 $486 - $1,059	2,863 New	2,863 $1,000
Q1 2022 May 02, 2022	SELL	$0.33 - $0.42 $944 - $1,202	-2,863 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$0.51 - $3.34 $321 - $2,104	630 Added 28.21%	2,863 $3,000
Q4 2020 Feb 17, 2021	BUY	$0.3 - $0.44 $669 - $982	2,233 New	2,233 $0
Q4 2019 Jan 29, 2020	SELL	$0.77 - $1.08 $2,951 - $4,139	-3,833 Closed	0 $0
Q3 2019 Oct 10, 2019	SELL	$1.0 - $2.97 $390 - $1,158	-390 Reduced 9.24%	3,833 $4,000
Q1 2019 Apr 12, 2019	SELL	$3.03 - $4.65 $442 - $678	-146 Reduced 3.34%	4,223 $20,000
Q3 2018 Oct 22, 2018	BUY	$1.6 - $2.03 $6,990 - $8,869	4,369 New	4,369 $8,000

Ticker AEZS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,855,880
Market Cap $19.4M
Description
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Truvestments Capital LLC with notifications on news.